Evaluation of nirsevimab against RSV infection in infants
KCE Rapid Response Reports (R³) 398C (2025)
How to refer to this report
Desimpel Fabian. Evaluation of nirsevimab against RSV infection in infants. Rapid Response Reports(R³). Brussels. Belgian Health Care Knowledge Centre (KCE). 2025. KCE Reports 398C. DOI: 10.57598/R398C.
